ArticleInternational journal of surgery case reports2026
Male breast carcinoma in a 45-year-old without known risk factors: case report and literature review.
Article in International journal of surgery case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Male breast carcinoma is an uncommon malignancy, accounting for approximately 1% of all breast neoplasms. Most cases usually occur after the age of 60 and often present in advanced stages. Case presentation: This is a case report of a 45-year-old male who presented with a lump in his left breast along with left axillary lymphadenopathy, without any known risk factors. Fine needle aspiration cytology of the lesion showed malignant epithelial cells consistent with ductal carcinoma. Core needle biopsy was advised; however, the patient underwent a left modified radical mastectomy at another center. Histopathological examination confirmed invasive ductal carcinoma. He received adjuvant chemotherapy and is currently undergoing adjuvant endocrine therapy. He is now clinically stable, with no evidence of local recurrence or distant metastasis 11 months after chemotherapy, and continues regular oncological follow-up. Clinical discussion: Male breast carcinoma usually occurs in the elderly population and is frequently associated with genetic and hormonal risk factors. Diagnosis relies on clinical assessment, imaging, and histopathological confirmation. A brief review of previously reported cases demonstrates invasive ductal carcinoma as the most common histological subtype. Conclusion: Breast carcinoma should always be considered as one of the differential diagnoses for a male breast lump. Prompt evaluation with appropriate imaging and tissue diagnosis is essential for timely management and improved outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.